BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rafaqat S, Rafaqat S. Role of IL-2/IL-2 receptor in pathogenesis of autoimmune disorders: Genetic and therapeutic aspects. World J Med Genet 2023; 11(3): 28-38 [DOI: 10.5496/wjmg.v11.i3.28]
URL: https://www.wjgnet.com/2220-3184/full/v11/i3/28.htm
Number Citing Articles
1
Che Ghazali Norul Hajar, Hisham Atan Edinur, Citra Manela, Fika Tri Anggraini. DNA in Health, Identity, and Ancestry2026; : 399 doi: 10.1016/B978-0-443-33947-9.00027-X
2
Fatemeh Rangani, Mohammad Ali Nahayati, Majid Pahlevan Kakhki, Seyed Hamid Aghaee-Bakhtiari. Ocrelizumab modulates the IL-2 signaling pathway and associated lncRNAs in multiple sclerosisJournal of the Neurological Sciences 2026; 480: 125693 doi: 10.1016/j.jns.2025.125693
3
Maryam Masoumi, Mahdi Solaymani, Mitra Abbasifard, Sheyda Houshmandfar, Parnia Iravani, Ali Saeedi-Boroujeni, Jafar Karami. The genetic puzzle of rheumatoid arthritis: Causes, progression, and treatmentBiochemistry and Biophysics Reports 2025; 43: 102148 doi: 10.1016/j.bbrep.2025.102148
4
Chantal Hof, Adrian Angenendt, Sandra Janku, Lukas Jarzembowski, Kathleen Seelert, Dorina Zöphel, Markus Hoth, Annette Lis. Elderly female CTLs maintain their initial activation and cytotoxicity independent of IL-2Immunity & Ageing 2025; 22(1) doi: 10.1186/s12979-025-00546-4
5
Morteza Rajabi, Sajjad Shafaeibajestan, Sevda Asadpour, Ghazal Alyari, Niloofar Taei, Moein Kohkalani, Ramin Raoufinia, Hamed Afarande, Ehsan Saburi. Primary Progressive Multiple Sclerosis: New Therapeutic ApproachesNeuropsychopharmacology Reports 2025; 45(3) doi: 10.1002/npr2.70039